Dysfunctional ErbB2, an EGF receptor family member, hinders repair of airway epithelial cells from asthmatic patients.

Asthma air-liquid interface culture airway inflammation cell proliferation cyclin D1 epidermal growth factor receptor epithelial cell erythroblastosis oncogene B2 wound repair

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
06 2019
Historique:
received: 18 06 2018
revised: 26 11 2018
accepted: 30 11 2018
pubmed: 15 1 2019
medline: 9 6 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Genetic and genomic data increasingly point to the airway epithelium as critical to asthma pathogenesis. Epithelial growth factor (EGF) family members play a fundamental role in epithelial differentiation, proliferation, and repair. Although expression of erythroblastosis oncogene B2 (ErbB2) mRNA, an EGF family receptor, was reported to be lower in asthmatic patients, little is understood about its functional role. We sought to determine whether decreased ErbB2 activation in freshly isolated human airway epithelial cells (HAECs) from asthmatic patients associated with impaired wound closure in vitro. An in vitro scratch-wound model of air-liquid interface cultured and freshly isolated HAECs were compared between HAECs from healthy control subjects (HCs) and asthmatic patients in relation to ErbB2. Freshly brushed HAECs from asthmatic patients had impaired ErbB2 activation compared with those from HCs. In an in vitro scratch-wound model, HAECs from asthmatic patients showed delayed wound closure compared with HAECs from HCs. Cell proliferation, as assessed based on [ These results implicate a primary defect in the ErbB2 pathway as constraining epithelial repair processes in asthmatic patients. Restoration of homeostatic ErbB2 function should be considered a novel asthma therapeutic target.

Sections du résumé

BACKGROUND
Genetic and genomic data increasingly point to the airway epithelium as critical to asthma pathogenesis. Epithelial growth factor (EGF) family members play a fundamental role in epithelial differentiation, proliferation, and repair. Although expression of erythroblastosis oncogene B2 (ErbB2) mRNA, an EGF family receptor, was reported to be lower in asthmatic patients, little is understood about its functional role.
OBJECTIVE
We sought to determine whether decreased ErbB2 activation in freshly isolated human airway epithelial cells (HAECs) from asthmatic patients associated with impaired wound closure in vitro.
METHODS
An in vitro scratch-wound model of air-liquid interface cultured and freshly isolated HAECs were compared between HAECs from healthy control subjects (HCs) and asthmatic patients in relation to ErbB2.
RESULTS
Freshly brushed HAECs from asthmatic patients had impaired ErbB2 activation compared with those from HCs. In an in vitro scratch-wound model, HAECs from asthmatic patients showed delayed wound closure compared with HAECs from HCs. Cell proliferation, as assessed based on [
CONCLUSION
These results implicate a primary defect in the ErbB2 pathway as constraining epithelial repair processes in asthmatic patients. Restoration of homeostatic ErbB2 function should be considered a novel asthma therapeutic target.

Identifiants

pubmed: 30639343
pii: S0091-6749(19)30008-9
doi: 10.1016/j.jaci.2018.11.046
pmc: PMC6556416
mid: NIHMS1020874
pii:
doi:

Substances chimiques

ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2075-2085.e10

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR024153
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL069174
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL144418
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI106684
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI040600
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL109152
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

FASEB J. 2000 Jul;14(10):1362-74
pubmed: 10877829
Oncogene. 2000 Dec 11;19(53):6102-14
pubmed: 11156523
Am J Respir Crit Care Med. 2001 Feb;163(2):517-23
pubmed: 11179133
Endocr Relat Cancer. 2001 Mar;8(1):11-31
pubmed: 11350724
Eur J Cancer. 2001 Sep;37 Suppl 4:S3-8
pubmed: 11597398
Am J Respir Cell Mol Biol. 2001 Dec;25(6):739-43
pubmed: 11726400
Am J Respir Cell Mol Biol. 2002 Sep;27(3):306-13
pubmed: 12204892
Am J Respir Cell Mol Biol. 2003 Jan;28(1):61-8
pubmed: 12495933
Nature. 2003 Mar 20;422(6929):322-6
pubmed: 12646923
J Biol Chem. 2004 Nov 26;279(48):50004-11
pubmed: 15377668
Am J Pathol. 2004 Oct;165(4):1097-106
pubmed: 15466377
Nat Rev Cancer. 2005 May;5(5):341-54
pubmed: 15864276
J Clin Invest. 2006 Feb;116(2):309-21
pubmed: 16453019
Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L175-80
pubmed: 16489114
Mol Biol Cell. 2006 Jul;17(7):2931-41
pubmed: 16624867
J Allergy Clin Immunol. 2006 Jun;117(6):1446-54
pubmed: 16751012
Int J Urol. 2006 May;13(5):587-92
pubmed: 16771730
FASEB J. 2008 Feb;22(2):455-65
pubmed: 17855624
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15858-63
pubmed: 17898169
Clin Exp Allergy. 2008 Jun;38(6):936-46
pubmed: 18384429
Clin Exp Allergy. 2008 Dec;38(12):1901-10
pubmed: 19037965
Nat Rev Cancer. 2009 Jul;9(7):463-75
pubmed: 19536107
J Allergy Clin Immunol. 2009 Nov;124(5):913-20.e1-7
pubmed: 19895983
Am J Respir Crit Care Med. 2010 May 1;181(9):889-98
pubmed: 20110557
N Engl J Med. 2010 Sep 23;363(13):1211-1221
pubmed: 20860503
Exp Cell Res. 2011 Aug 1;317(13):1947-53
pubmed: 21624363
J Allergy Clin Immunol. 2011 Sep;128(3):549-56.e1-12
pubmed: 21752437
Thorax. 2012 Sep;67(9):762-8
pubmed: 22561531
Nat Med. 2012 May 04;18(5):684-92
pubmed: 22561832
Am J Respir Crit Care Med. 2012 Nov 15;186(10):965-74
pubmed: 22955319
J Allergy Clin Immunol. 2012 Dec;130(6):1243-55
pubmed: 23026498
Hum Immunol. 2013 Feb;74(2):256-60
pubmed: 23200760
Chest. 2013 Dec;144(6):1906-1912
pubmed: 24297122
Cells. 2014 Apr 22;3(2):304-30
pubmed: 24758840
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1363-72
pubmed: 25338189
Nat Mater. 2015 Oct;14(10):1040-8
pubmed: 26237129
JCI Insight. 2016 Dec 8;1(20):e90151
pubmed: 27942592
Am J Respir Crit Care Med. 2017 Jun 1;195(11):1449-1463
pubmed: 27984699
Nat Genet. 2018 Jan;50(1):42-53
pubmed: 29273806
Sci Rep. 2018 Jan 24;8(1):1511
pubmed: 29367592
Science. 1987 Jan 9;235(4785):177-82
pubmed: 3798106
Nature. 1995 Nov 23;378(6555):394-8
pubmed: 7477377
In Vitro Cell Dev Biol Anim. 1993 May;29A(5):379-87
pubmed: 7686141

Auteurs

Hideki Inoue (H)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa; Division of Pulmonary and Allergy Medicine, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Takeshi Hattori (T)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.

Xiuxia Zhou (X)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.

Emily B Etling (EB)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.

Brian D Modena (BD)

Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, Calif; Department of Allergy, Asthma and Immunology, Scripps Health, San Diego, Calif.

John B Trudeau (JB)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.

Fernando Holguin (F)

Division of Medicine-Pulmonary Sciences & Critical Care, University of Colorado School of Medicine, Aurora, Colo.

Sally E Wenzel (SE)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pa. Electronic address: SWENZEL@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH